Skip to main content
Premium Trial:

Request an Annual Quote

Monsanto Licenses ToolGen CRISPR Technology

NEW YORK (GenomeWeb) – Monsanto announced today that it has licensed a CRISPR technology platform from Korean biotechnology company ToolGen with the intention of developing agricultural products.

The global license provides Monsanto with access to ToolGen's comprehensive suite of CRISPR intellectual property for use in plants. The agreement will also expand Monsanto's portfolio of gene editing tools, which the company plans to use to develop improved and sustainable crops.

Specific terms of the deal were not disclosed.

"We are excited to bring ToolGen's CRISPR platform on board at Monsanto, and are continuing to bolster and diversify our capabilities in this field of research," Tom Adams, vice president of biotechnology for Monsanto, said in a statement. "[We] look forward to leveraging the CRISPR platform as we endeavor to meet the needs of farmers while answering consumer demand for food options."